Premium
A phase II trial of erlotinib and bevacizumab for patients with metastatic melanoma
Author(s) -
Mudigonda Tejaswi V.,
Wyman Kenneth,
Spigel David R.,
Dahlman Kimberly B.,
Greco F. Anthony,
Puzanov Igor,
Kelley Mark C.,
Hainsworth John D.,
Sosman Jeffrey A.,
Johnson Douglas B.
Publication year - 2016
Publication title -
pigment cell and melanoma research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.618
H-Index - 105
eISSN - 1755-148X
pISSN - 1755-1471
DOI - 10.1111/pcmr.12394
Subject(s) - bevacizumab , erlotinib , medicine , metastatic melanoma , table (database) , oncology , cancer , computer science , database , chemotherapy , epidermal growth factor receptor
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom